0.6109
price up icon2.55%   0.0198
after-market 시간 외 거래: .61 -0.0009 -0.15%
loading
전일 마감가:
$0.5911
열려 있는:
$0.61
하루 거래량:
631.32K
Relative Volume:
0.74
시가총액:
$73.69M
수익:
-
순이익/손실:
$-30.54M
주가수익비율:
-0.3941
EPS:
-1.55
순현금흐름:
$-18.30M
1주 성능:
+6.35%
1개월 성능:
-6.54%
6개월 성능:
-10.58%
1년 성능:
-27.46%
1일 변동 폭
Value
$0.5951
$0.62
1주일 범위
Value
$0.541
$0.62
52주 변동 폭
Value
$0.202
$0.9598

Unicycive Therapeutics Inc Stock (UNCY) Company Profile

Name
명칭
Unicycive Therapeutics Inc
Name
전화
650-384-0642
Name
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Name
직원
22
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
UNCY's Discussions on Twitter

UNCY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
UNCY
Unicycive Therapeutics Inc
0.6109 72.38M 0 -30.54M -18.30M -1.55
Biotechnology icon
ONC
Beigene Ltd Adr
240.41 25.61B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.28 114.83B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 41.82M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.43 66.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.93 6.36B 0 -153.72M -103.81M -2.00

Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-21 개시 Guggenheim Buy
2024-04-04 개시 Piper Sandler Overweight

Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스

pulisher
09:04 AM

Unicycive Therapeutics (NASDAQ:UNCY) Upgraded to “Strong-Buy” at HC Wainwright - Defense World

09:04 AM
pulisher
May 27, 2025

Unicycive Therapeutics (UNCY): HC Wainwright & Co. Sets Price Target | UNCY Stock News - GuruFocus

May 27, 2025
pulisher
May 22, 2025

Unicycive Therapeutics CEO Shalabh Gupta to Present at Upcoming Investor Conferences - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Unicycive Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Unicycive Therapeutics to Present at Upcoming Investor Conferences - GlobeNewswire Inc.

May 22, 2025
pulisher
May 21, 2025

Benchmark maintains $3 target on Unicycive stock post-Q1 filings By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

Unicycive Therapeutics Updates Annual Meeting Time - TipRanks

May 21, 2025
pulisher
May 21, 2025

Unicycive Therapeutics (UNCY) Alters 2025 Shareholder Meeting Time | UNCY Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Unicycive Therapeutics Updates Annual Meeting Schedule: Key Details for Kidney Disease Biotech Investors - Stock Titan

May 21, 2025
pulisher
May 19, 2025

These Numbers Show Just How Powerful Unicycive Therapeutics Inc (NASDAQ: UNCY) Stock ‎Is - Stocksregister

May 19, 2025
pulisher
May 19, 2025

Q2 Earnings Forecast for UNCY Issued By Noble Financial - Defense World

May 19, 2025
pulisher
May 15, 2025

Data-Based Analysis Of Unicycive Therapeutics Inc (UNCY) - Stocksregister

May 15, 2025
pulisher
May 14, 2025

Unicycive (UNCY) Advances Toward FDA Approval for Key Kidney Disease Drug | UNCY Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Unicycive Reports Strong Q1 Results as Game-Changing Kidney Drug Nears FDA Decision Date - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Unicycive Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Unicycive Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 14, 2025
pulisher
May 10, 2025

Unicycive Therapeutics (UNCY) Projected to Post Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 07, 2025

Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long - Yahoo Finance

May 07, 2025
pulisher
May 03, 2025

Geode Capital Management LLC Acquires 122,089 Shares of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Defense World

May 03, 2025
pulisher
May 01, 2025

Insider’s View: Deciphering Unicycive Therapeutics Inc (UNCY)’s Financial Health Through Ratios - DWinneX

May 01, 2025
pulisher
May 01, 2025

Unicycive Therapeutics Inc (UNCY)’s stock performance: a year in review - uspostnews.com

May 01, 2025
pulisher
Apr 30, 2025

XTX Topco Ltd Raises Stock Position in Unicycive Therapeutics, Inc. (NASDAQ:UNCY) - Defense World

Apr 30, 2025
pulisher
Apr 25, 2025

Ratios Uncovered: Breaking Down Unicycive Therapeutics Inc (UNCY)’s Trailing Twelve Months Metrics - DWinneX

Apr 25, 2025
pulisher
Apr 23, 2025

What is the investor’s view on Unicycive Therapeutics Inc (UNCY)? - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Guggenheim Begins Coverage on Unicycive Therapeutics (NASDAQ:UNCY) - The AM Reporter

Apr 23, 2025
pulisher
Apr 22, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Coverage Initiated by Analysts at Guggenheim - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

Guggenheim Initiates Coverage of Unicycive Therapeutics (UNCY) with Buy Recommendation - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Guggenheim Initiates Unicycive Therapeutics at Buy With $6 Price Target - marketscreener.com

Apr 21, 2025
pulisher
Apr 19, 2025

Unicycive Announces Second Quarter 2024 Financial Results and Provides Business Update - ADVFN

Apr 19, 2025
pulisher
Apr 13, 2025

HC Wainwright Reiterates “Buy” Rating for Unicycive Therapeutics (NASDAQ:UNCY) - Defense World

Apr 13, 2025
pulisher
Apr 11, 2025

H.C. Wainwright maintains Unicycive Buy rating, $7.50 target By Investing.com - Investing.com Canada

Apr 11, 2025
pulisher
Apr 11, 2025

Unicycive Therapeutics: Buy Rating on Imminent FDA Approval and Market Potential of Oxylanthanum Carbonate - TipRanks

Apr 11, 2025
pulisher
Apr 10, 2025

Unicycive Presents New Patient-Level Data Underscoring Challenges Faced with Current Phosphate Binders and Highlighting the Potential of Oxylanthanum Carbonate to Address Barriers to Adherence for Patients with Hyperphosphatemia on Dialysis - GlobeNewswire

Apr 10, 2025
pulisher
Apr 10, 2025

Breakthrough: Unicycive's New Kidney Drug Cuts Pills in Half, 98% of Patients Report Easy Use - Stock Titan

Apr 10, 2025
pulisher
Apr 08, 2025

Unicycive Therapeutics Inc Inc. (UNCY) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 08, 2025
pulisher
Apr 07, 2025

60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R) - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 05, 2025

HC Wainwright Issues Pessimistic Estimate for UNCY Earnings - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

UNCY FY2025 EPS Lifted by Brookline Capital Management - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

Brookline Capital Management Weighs in on UNCY Q1 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

HC Wainwright Issues Positive Forecast for Unicycive Therapeutics (NASDAQ:UNCY) Stock Price - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Unicycive stock target raised to $7.50 by H.C. Wainwright - Investing.com Canada

Apr 01, 2025
pulisher
Apr 01, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Posts Quarterly Earnings Results, Misses Estimates By $0.13 EPS - MarketBeat

Apr 01, 2025
pulisher
Apr 01, 2025

Unicycive Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Exclusive Look: Unicycive Unveils Latest Kidney Disease Breakthroughs at Major Healthcare Conference - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Unicycive Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

FDA to Review Unicycive's Kidney Disease Drug in June 2025: Key Financial Updates - Stock Titan

Mar 31, 2025
pulisher
Mar 27, 2025

Unicycive Approaches Its First Approval, But In A Competitive Space - insights.citeline.com

Mar 27, 2025
pulisher
Mar 25, 2025

Targeting Pressing Unmet Needs in Kidney Diseases with Unicycive Therapeutics CEO Dr. Shalabh Gupta - iHeart

Mar 25, 2025

Unicycive Therapeutics Inc (UNCY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.05
price down icon 9.13%
$30.27
price down icon 2.34%
$576.43
price down icon 0.98%
$285.56
price down icon 1.16%
$4.35
price up icon 1.64%
$73.93
price down icon 2.39%
자본화:     |  볼륨(24시간):